In our mouse diabetes model, we observed significant decreases in BCAA intermediates in liver, muscle and adipose tissues, as well as plasma, which strongly suggest that mitochondrial function is improved with R419 treatment and could contribute to the improvements in glucose and insulin tolerance observed in R419-treated db/db mice. Here, INS is linked to diabetes mellitus.